MedPath

Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery

Not Applicable
Recruiting
Conditions
Cardiac Surgery
Disorder
Postoperative
Heart
Interventions
Other: Restrictive Transfusion Strategy
Other: Liberal transfusion strategy
Registration Number
NCT04754022
Lead Sponsor
Unity Health Toronto
Brief Summary

TRICS-IV is an international, multi-centre, open-label randomized controlled trial of two commonly used transfusion strategies in moderate to high risk patients who are 65 years of age or younger undergoing cardiac surgery on cardiopulmonary bypass, using a superiority trial design.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1440
Inclusion Criteria
  1. ≥18 and ≤65 years of age
  2. Planned cardiac surgery using cardiopulmonary bypass
  3. Informed consent obtained
  4. Preoperative European System for Cardiac Operative Risk Evaluation (EuroSCORE I) of 6 or more
Exclusion Criteria
  1. Patients who refuse participation
  2. Patients who are unable to receive or who refuse blood products
  3. Patients who are involved in a preoperative autologous pre-donation program
  4. Patients who are having a heart transplant or having surgery solely for an insertion of a ventricular assist device
  5. Pregnancy or lactation (a negative pregnancy test must be obtained prior to randomization for women of childbearing potential)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Restrictive Transfusion StrategyRestrictive Transfusion StrategyPatients will receive a RBC transfusion if their Hb concentration is \<75 g/L (\<7.5 g/dL; \<4.7mmol/L) intraoperatively and/or postoperatively.
Liberal Transfusion StrategyLiberal transfusion strategyPatients will receive a RBC transfusion if their Hb concentration is \<95 g/L (\<9.5 g/dL; \<5.9mmol/L) intraoperatively, or postoperatively in the ICU; and/or \<85 g/L (\< 8.5 g/dL; \<5.3mmol/L) on the ward.
Primary Outcome Measures
NameTimeMethod
Composite score of any one of the following events occurring 6 months after cardiac surgery: (1) all-cause mortality; (2) myocardial infarction; (3) new onset renal failure requiring dialysis; or (4) new focal neurological deficit (stroke).Within 6 months after cardiac surgery.

Any of all-cause mortality, myocardial infarction, new onset renal failure requiring dialysis, or new focal neurological deficit (stroke).

Secondary Outcome Measures
NameTimeMethod
Composite and individual all-cause mortality, myocardial infarction, new onset renal failure requiring dialysis, and new focal neurological deficit (stroke).Up to hospital discharge or after 28 days postoperatively, whichever comes first.

Composite and individual incidence of all-cause mortality, myocardial infarction, new onset renal failure requiring dialysis, and new focal neurological deficit (stroke).

Length of stay in the ICU and hospital.Up to hospital discharge or after 28 days postoperatively, whichever comes first.

Length of stay in the ICU and hospital in days.

Acute kidney injury.Up to hospital discharge or after 28 days postoperatively, whichever comes first.

Defined by the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guideline - a 50% increase in serum creatinine within 1 week or a 26.5 mmol/L increase within 48 hours.

Duration of mechanical ventilation.Up to hospital discharge or after 28 days postoperatively, whichever comes first.

Time on mechanical ventilation.

Incidence of infection.Up to hospital discharge or after 28 days postoperatively, whichever comes first.

Defined as septic shock with positive blood cultures; pneumonia defined as autopsy diagnosis or roentgenographic infiltrate and at least two out of three of the following criteria: fever, leukocytosis, and positive sputum culture; and/or deep sternal or leg wound infection requiring intravenous antibiotics and/or surgical debridement.

Prolonged low output state.Up to hospital discharge or after 28 days postoperatively, whichever comes first.

Defined as the need for two or more inotropes for 24 hours or more, intra-aortic balloon pump or ventricular assist device postoperatively.

Delirium.Up to hospital discharge or after 28 days postoperatively, whichever comes first.

Confusion Assessment Method (CAM) or CAM-ICU (even on 1 occasion), or Intensive Care Delirium Screening Checklist (ICDSC) \> 3, or 3D-CAM, or 4AT ≥4, or more than one dose of haloperidol or similar antipsychotic drug, or documented delirium by neurologist or neurosurgeon or psychiatrist consultation.

Hospital visits.Within 6 months after cardiac surgery.

Hospitalization and/or emergency visits and coronary revascularization after index procedure.

Incidence of encephalopathy.Up to hospital discharge or after 28 days postoperatively, whichever comes first.

Unexpected delayed awakening or severely altered mental status (unconscious despite no sedative medication for more than 5 days), or encephalopathy documented by neurologist or neurosurgeon or psychiatrist consultation.

Incidence of each individual component of the primary outcome: all-cause mortality, myocardial infarction, new onset renal failure requiring dialysis, and new focal neurological deficit (stroke).Within 6 months after cardiac surgery.

Incidence of all-cause mortality, myocardial infarction, new onset renal failure requiring dialysis, and new focal neurological deficit (stroke).

Incidence of gut infarction.Up to hospital discharge or after 28 days postoperatively, whichever comes first.

Confirmed by imaging (e.g. angiography), autopsy, or through surgical means.

Incidence of seizures.Up to hospital discharge or after 28 days postoperatively, whichever comes first.

Generalized or focal tonic-clonic movements consistent with seizure; or electroencephalogram demonstrating epileptiform discharges; or diagnosis of seizures by neurologist or neurosurgeon consultation.

Transfusion requirements.Up to hospital discharge or after 28 days postoperatively, whichever comes first.

The proportion of patients transfused and the number of blood products utilized (RBCs, plasma, platelets).

Trial Locations

Locations (54)

Maine Medical Center

🇺🇸

Portland, Maine, United States

The Cooper Health System

🇺🇸

Camden, New Jersey, United States

Columbia University

🇺🇸

New York, New York, United States

Thomas Jefferson University

🇺🇸

Philadelphia, Pennsylvania, United States

Royal Prince Alfred hospital

🇦🇺

Camperdown, New South Wales, Australia

Prince of Wales Hospital

🇦🇺

Randwick, New South Wales, Australia

Westmead Hospital

🇦🇺

Westmead, New South Wales, Australia

Gold Coast University Hospital

🇦🇺

Southport, Queensland, Australia

Flinders Medical Centre

🇦🇺

Bedford Park, South Australia, Australia

Monash Health

🇦🇺

Clayton, Victoria, Australia

St Vincent's Hospital Melbourne

🇦🇺

Fitzroy, Victoria, Australia

Austin Health

🇦🇺

Heidelberg, Victoria, Australia

Royal Adelaide Hospital

🇦🇺

Adelaide, Australia

Royal Melbourne Hospital

🇦🇺

Melbourne, Australia

Alfred Hospital

🇦🇺

Prahran, Australia

University of Alberta Hospital

🇨🇦

Edmonton, Alberta, Canada

Vancouver General Hospital

🇨🇦

Vancouver, British Columbia, Canada

Kingston Health Sciences Centre

🇨🇦

Kingston, Ontario, Canada

Health Sciences North Research Institute

🇨🇦

Sudbury, Ontario, Canada

Sunnybrook Health Sciences Center

🇨🇦

Toronto, Ontario, Canada

Toronto General Hospital

🇨🇦

Toronto, Ontario, Canada

Montreal Heart Institute

🇨🇦

Montreal, Quebec, Canada

Jewish General Hospital

🇨🇦

Montreal, Quebec, Canada

Hôpital Sacré-Cœur de Montréal

🇨🇦

Montréal, Quebec, Canada

Hospital Universitario San Ignacio

🇨🇴

Bogota, Colombia

Fundacion Abood Shaio

🇨🇴

Bogota, Colombia

Fundacion Cardioinfantil

🇨🇴

Bogota, Colombia

Nasr City Health Insurance Hospital

🇪🇬

Naşr, Cairo, Egypt

Democritus University of Thrace

🇬🇷

Alexandroupolis, Evros, Greece

EPIC Hospital

🇮🇳

Ahmedabad, Gujrat, India

Windhoek Central Hospital

🇳🇦

Windhoek, Khomas, Namibia

Shahid Gangalal National Heart Center

🇳🇵

Kathmandu, Nepal

Emergency Institute of Cardiovascular Diseases

🇷🇴

Bucharest, Romania

National Heart Centre

🇸🇬

Singapore, Singapore

Charlotte Maxeke Johannesburg Academic Hospital

🇿🇦

Johannesburg, Gauteng, South Africa

Hospital de la Santa Creu I Sant Pau

🇪🇸

Barcelona, Catalonia, Spain

Hospital General Universitari de Valencia

🇪🇸

Valencia, Spain

Hospital Universitario La Fe Valencia

🇪🇸

Valencia, Spain

University Hospital Basel

🇨🇭

Basel, Switzerland

Inselspital, University Hospital Bern, University of Bern

🇨🇭

Bern, Switzerland

University Hospital Leicester

🇬🇧

Leicester, East Midlands, United Kingdom

Basildon University Hospitals-Mid and South Essex NHS Trust

🇬🇧

Basildon, Essex, United Kingdom

University Hospital Southampton Foundation Trust

🇬🇧

Southampton, Hampshire, United Kingdom

University Hospitals Sussex NHS Foundation Trust

🇬🇧

Brighton, United Kingdom

University Hospitals Bristol and Weston NHS Foundation Trust

🇬🇧

Bristol, United Kingdom

Royal Papworth Hospital NHS Foundation Trust.

🇬🇧

Cambridge, United Kingdom

Manchester University NHS Foundation Trust

🇬🇧

Wythenshawe, United Kingdom

Interior Health Kelowna General Hospital

🇨🇦

Kelowna, British Columbia, Canada

Saint John Regional Hospitall

🇨🇦

Saint John, New Brunswick, Canada

Hamilton Health Sciences Centre / Hamilton General Hospital

🇨🇦

Hamilton, Ontario, Canada

St. Michael's Hospital, Unity Health Toronto

🇨🇦

Toronto, Ontario, Canada

Centre hospitalier de l'Université de Montréal

🇨🇦

Montréal, Quebec, Canada

Institut universitaire de cardiologie et de pneumology de Québec - université Laval (IUCPQ-UL)

🇨🇦

Québec, Quebec, Canada

Saint-Petersburg State University Hospital

🇷🇺

Saint Petersburg, Russian Federation

© Copyright 2025. All Rights Reserved by MedPath